Skip to main content
. Author manuscript; available in PMC: 2014 Jun 15.
Published in final edited form as: Cancer Res. 2013 Oct 11;73(24):7162–7167. doi: 10.1158/0008-5472.CAN-13-2498

Table 4.

Correlation of TERT promoter mutation status and tumor progression

Progression
on follow-up		 Number of
patients		 TERT
mutation
present (%)		 TERT mutation
absent (%)		 P
pTa LG (N =28) Yes 6 6/6  (100%) 0/6  (0%) 0.31
No 22 17/22 (77%) 3/22 (14%)
pTa HG (N =31)a Yes 5 4/5  (80%) 1/5  (20%) 0.45
No 24 15/24 (63%) 9/24 (38%)
CIS(N =17) Yes 4 3/4  (75%) 1/4  (25%) 0.60
No 13 8/13  (62%) 5/13 (39%)
a

Progression status was not available in two cases. CIS: Carcinoma in situ; HG: high-grade noninvasive urothelial carcinoma; LG: low-grade noninvasive urothelial carcinoma; NA: not available.